'Why I blame Johnson and Johnson baby talc for cancer that robbed me of my voice'
Cassandra Wardle was just 44 when she was diagnosed with ovarian cancer, like many babies her mum used talc on her trusting ...
Johnson & Johnson’s Promising Pharmaceutical Developments Justify Buy Rating
Leerink Partners analyst David Risinger has maintained their bullish stance on JNJ stock, giving a Buy rating on November 14.Don't Miss our ...